Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies
Advances in Protein Chemistry and Structural Biology · 2025
DOI: 10.1016/bs.apcsb.2025.08.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2025. Verfasst von Asma Shah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Kashmir, India. Hauptthemen laut MEDLINE: Protein Folding, Neurodegenerative Diseases, Proteostasis Deficiencies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 237 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research.
Abstract (Originalsprache)
Protein misfolding and aggregation play a pivotal role in the development of neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's disease, and other related disorders. Proper protein folding is essential for cellular function, but due to the complexity of the folding process and external factors like genetic mutations, oxidative stress, and aging, misfolding is inevitable. These misfolded proteins often aggregate into toxic forms that disrupt cellular processes, leading to neuronal damage and cognitive decline. This chapter provides a comprehensive overview of molecular mechanisms behind protein misfolding, highlighting how these abnormal structures contribute to neurodegeneration. It also explores the role of the proteostasis network and its therapeutic potential in alleviating these processes. Focusing on multitarget therapeutic strategies, the chapter offers insights into promising approaches for addressing the root causes of neurodegenerative diseases while identifying key research gaps that could shape future treatment developments. By blending current knowledge with emerging therapeutic directions, this chapter provides a comprehensive and engaging perspective on combating the challenges of protein misfolding in neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Kashmir, India.
- Metabolic and Mendelian Disorders Clinical Research Program and Precision OMICs Research & Translational Science, Sidra Medicine, Doha, Qatar.
- Department of Human Genetics, Sidra Medicine, Doha, Qatar.
- School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.
- Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Kashmir, India. Electronic address: muzafar.macha@iust.ac.in.
Förderung
- Science and Engineering Research Board
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Council of Medical Research
Zitieren
APA
Shah, A., Karthikeyan, T., Hashem, S., Kumar, R., Bhat, A. A., & Macha, M. A. (2025). Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2025.08.012
Vancouver
Shah A, Karthikeyan T, Hashem S, Kumar R, Bhat AA, Macha MA. Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies. Advances in Protein Chemistry and Structural Biology. 2025. doi:10.1016/bs.apcsb.2025.08.012
BibTeX
@article{Shah2025,
author = {Shah, Asma and Karthikeyan, Tharini and Hashem, Sheema and Kumar, Rakesh and Bhat, Ajaz A and Macha, Muzafar A},
title = {Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies},
journal = {Advances in Protein Chemistry and Structural Biology},
year = {2025},
doi = {10.1016/bs.apcsb.2025.08.012}
}
EUVIMED